Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement-Reference-Cited by-同舟云学术

Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement

Published:2021-11 Issue: Volume: Page:
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Pan Zhidi,Chen Jie,Xiao Xiaodong,Xie Yueqing^ORCID,Jiang Hua,Zhang Baohong,Lu Huili,Yuan Yunsheng,Han Lei,Zhou Yuexian,Zong Huifang^ORCID,Wang Lei^ORCID,Sun Rui,Zhu Jianwei

Funder

National Natural Science Foundation of China

National Major Science and Technology Projects of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference56 articles.

1. Bispecific antibodies: a mechanistic review of the pipeline;Labrijn;Nat Rev Drug Discov,2019

2. Abstract #3252: effector memory T cells make a major contribution to redirected target cell lysis by T cell-engaging BiTE antibody MT110;Kischel;Cancer Res,2009

3. Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody;Choi;Cancer Immunol Res,2013

4. An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors;Ishiguro;Sci Transl Med,2017

5. A novel carcinoembryonic antigen T-cell bispecific antibody (CEA TCB) for the treatment of solid tumors;Bacac;Clin Cancer Res,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors;International Immunopharmacology;2024-09

2. Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format;Cancer Immunology, Immunotherapy;2024-08-06

3. Dysfunction of dendritic cells in tumor microenvironment and immunotherapy;Cancer Communications;2024-07-25

4. T cell-redirecting antibody for treatment of solid tumors via targeting mesothelin;Acta Pharmacologica Sinica;2024-06-10

5. Characterization of a novel T cell-engaging bispecific antibody for elimination of L1CAM-positive tumors;Biomedicine & Pharmacotherapy;2024-05